Copyright
©The Author(s) 2015.
World J Gastroenterol. Apr 28, 2015; 21(16): 4919-4924
Published online Apr 28, 2015. doi: 10.3748/wjg.v21.i16.4919
Published online Apr 28, 2015. doi: 10.3748/wjg.v21.i16.4919
Table 1 Clinical characteristics of patients according to proton-pump inhibitor use
| Characteristic | PPI group(n = 175) | Control group(n = 369) |
| Age, yr | 63.9 ± 12.8 | 62.7 ± 14.5 |
| Follow-up (mo) | 55.7 ± 33.6a | 66.5 ± 37.5 |
| Sex, male | 98 (57.1) | 201 (54.5) |
| Hypertension | 99 (56.6) | 215 (58.3) |
| Diabetes | 90 (51.4) | 203 (55.0) |
| Smoking | 11 (40.7) | 4 (12.1) |
| Hemodialysis | 153 (87.4) | 333 (90.24) |
| Body mass index (kg/m2) | 23.4 ± 3.2 | 23.5 ± 3.9 |
| Previous cardiovascular disease | ||
| Cerebrovascular accident | 18 (10.3) | 49 (13.3) |
| Coronary heart disease | 28 (16.0) | 68 (18.4) |
| Chronic liver disease | 2 (1.1) | 3 (0.8) |
| Aspirin use | 82 (46.9) | 175 (47.4) |
| Dual anti-platelet therapy | 15 (8.6) | 32 (8.7) |
| Warfarin | 9 (5.1) | 8 (2.2) |
| Helicobacter pyroli | ||
| Positive | 36 (6.0) | 53 (15.0) |
| No test | 139 (79.4) | 316 (85.6) |
| Baseline laboratory findings | ||
| Hemoglobin (g/L) | 9.1 ± 1.6 | 8.8 ± 1.6 |
| Hematocrit (%) | 27.3 ± 5.3 | 26.2 ± 5.1 |
| Creatinine (mmol/L) | 6.7 ± 2.9 | 7.2 ± 3.2 |
| Protein (g/L) | 7.3 ± 0.9 | 7.2 ± 0.9 |
| Albumin (g/L) | 4.1 ± 0.9 | 3.9 ± 0.6 |
| C-reactive protein (mg/L) | 11.0 ± 18.8 | 9.6 ± 17.2 |
| Death | 7 (4.0) | 18 (4.9) |
- Citation: Song YR, Kim HJ, Kim JK, Kim SG, Kim SE. Proton-pump inhibitors for prevention of upper gastrointestinal bleeding in patients undergoing dialysis. World J Gastroenterol 2015; 21(16): 4919-4924
- URL: https://www.wjgnet.com/1007-9327/full/v21/i16/4919.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i16.4919